1. Home
  2. ECDA vs GANX Comparison

ECDA vs GANX Comparison

Compare ECDA & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECDA
  • GANX
  • Stock Information
  • Founded
  • ECDA 2013
  • GANX 2017
  • Country
  • ECDA United States
  • GANX United States
  • Employees
  • ECDA N/A
  • GANX N/A
  • Industry
  • ECDA Auto Manufacturing
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECDA Consumer Discretionary
  • GANX Health Care
  • Exchange
  • ECDA Nasdaq
  • GANX Nasdaq
  • Market Cap
  • ECDA 36.4M
  • GANX 41.9M
  • IPO Year
  • ECDA N/A
  • GANX 2021
  • Fundamental
  • Price
  • ECDA $0.98
  • GANX $1.62
  • Analyst Decision
  • ECDA Strong Buy
  • GANX Strong Buy
  • Analyst Count
  • ECDA 1
  • GANX 4
  • Target Price
  • ECDA $9.00
  • GANX $7.75
  • AVG Volume (30 Days)
  • ECDA 45.5K
  • GANX 281.8K
  • Earning Date
  • ECDA 12-03-2024
  • GANX 11-14-2024
  • Dividend Yield
  • ECDA N/A
  • GANX N/A
  • EPS Growth
  • ECDA N/A
  • GANX N/A
  • EPS
  • ECDA N/A
  • GANX N/A
  • Revenue
  • ECDA $25,728,409.00
  • GANX N/A
  • Revenue This Year
  • ECDA $125.56
  • GANX N/A
  • Revenue Next Year
  • ECDA $36.05
  • GANX $300.03
  • P/E Ratio
  • ECDA N/A
  • GANX N/A
  • Revenue Growth
  • ECDA 123.27
  • GANX N/A
  • 52 Week Low
  • ECDA $0.75
  • GANX $0.89
  • 52 Week High
  • ECDA $17.00
  • GANX $5.33
  • Technical
  • Relative Strength Index (RSI)
  • ECDA 46.52
  • GANX 35.06
  • Support Level
  • ECDA $0.82
  • GANX $1.63
  • Resistance Level
  • ECDA $1.03
  • GANX $2.00
  • Average True Range (ATR)
  • ECDA 0.10
  • GANX 0.22
  • MACD
  • ECDA -0.01
  • GANX -0.08
  • Stochastic Oscillator
  • ECDA 53.33
  • GANX 7.23

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: